Activated protein C resistance and pregnancy complications [7]

American Journal of Obstetrics and Gynecology

Volumn 174, Issue 2, 1996, Pages 801-802

  Grisaru, D ^a   Fait, G ^a   Eldor, A ^a  

^a Serlin Maternity Hospital   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C;

ANTICOAGULANT THERAPY; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; GENE MUTATION; HUMAN; LETTER; MATERNAL HYPERTENSION; MESENTERIC VEIN THROMBOSIS; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SOLUTIO PLACENTAE; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOPHILIA; THROMBOSIS PREVENTION;

EID: 0029958920     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70478-7     Document Type: Letter

References (4)

1. B Dahlback Inherited resistance to activated protein c, a major cause of venous thrombosis, is due to a mutation in the factor V gene Haemostasis 24 1994 139 151
2. RM Bertina BPC Koeleman T Koster Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
3. PJ Svensson B Dahlback Resistance to activated protein C as a basis for venous thrombosis N Engl J Med 330 1994 517 522
4. JP Vandenbroucke T Koster E Briet PH Reistma RM Bertina FR Rosendaal Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation Lancet 344 1994 1453 1457